t-2 toxin has been researched along with benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone in 1 studies
| Studies (t-2 toxin) | Trials (t-2 toxin) | Recent Studies (post-2010) (t-2 toxin) | Studies (benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone) | Trials (benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone) | Recent Studies (post-2010) (benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone) |
|---|---|---|---|---|---|
| 1,345 | 13 | 513 | 1,897 | 0 | 411 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhaskar, AS; Chaudhari, M; Jayaraj, R; Lakshmana Rao, PV | 1 |
1 other study(ies) available for t-2 toxin and benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone
| Article | Year |
|---|---|
Oxidative stress induction by T-2 toxin causes DNA damage and triggers apoptosis via caspase pathway in human cervical cancer cells.
Topics: Amino Acid Chloromethyl Ketones; Apoptosis; Cell Survival; DNA Damage; DNA, Neoplasm; Female; Glutathione; HeLa Cells; Humans; Lipid Peroxidation; Malondialdehyde; Mitochondria; Neuroprotective Agents; Oxidative Stress; Signal Transduction; T-2 Toxin; Tumor Suppressor Protein p53; Uterine Cervical Neoplasms | 2009 |